A phase Ib study exploring the combination of everolimus and dovitinib in VEGF-refractory clear cell renal cancer.
Amanda Marie Fitzpatrick
No relevant relationships to disclose
Michelle Greenwood
No relevant relationships to disclose
Abigail Foreshew
No relevant relationships to disclose
Jude Nixon
No relevant relationships to disclose
Anju Sahdev
No relevant relationships to disclose
Naveed Sarwar
No relevant relationships to disclose
Louise Lim
No relevant relationships to disclose
Robert J. Jones
Honoraria - Novartis; Pfizer
Simon Chowdhury
Honoraria - Novartis; Pfizer
Simon J. Crabb
Honoraria - Novartis; Pfizer
Thomas Powles
Honoraria - Novartis; Pfizer